Alison E. John
COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
John, Alison E.; Joseph, Chitra; Jenkins, Gisli; Tatler, Amanda L.
Authors
Dr CHITRA JOSEPH CHITRA.JOSEPH@NOTTINGHAM.AC.UK
Research Fellow
Gisli Jenkins
AMANDA TATLER AMANDA.TATLER@NOTTINGHAM.AC.UK
Principal Research Fellow
Abstract
The COVID-19 pandemic rapidly spread around the world following the first reports in Wuhan City, China in late 2019. The disease, caused by the novel SARS-CoV-2 virus, is primarily a respiratory condition that can affect numerous other bodily systems including the cardiovascular and gastrointestinal systems. The disease ranges in severity from asymptomatic through to severe acute respiratory distress requiring intensive care treatment and mechanical ventilation, which can lead to respiratory failure and death. It has rapidly become evident that COVID-19 patients can develop features of interstitial pulmonary fibrosis, which in many cases persist for as long as we have thus far been able to follow the patients. Many questions remain about how such fibrotic changes occur within the lung of COVID-19 patients, whether the changes will persist long term or are capable of resolving, and whether post-COVID-19 pulmonary fibrosis has the potential to become progressive, as in other fibrotic lung diseases. This review brings together our existing knowledge on both COVID-19 and pulmonary fibrosis, with a particular focus on lung epithelial cells and fibroblasts, in order to discuss common pathways and processes that may be implicated as we try to answer these important questions in the months and years to come.
Citation
John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021). COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts. Immunological Reviews, 302(1), 228-240. https://doi.org/10.1111/imr.12977
Journal Article Type | Article |
---|---|
Acceptance Date | May 3, 2021 |
Online Publication Date | May 24, 2021 |
Publication Date | 2021-07 |
Deposit Date | May 27, 2021 |
Publicly Available Date | May 27, 2021 |
Journal | Immunological Reviews |
Print ISSN | 0105-2896 |
Electronic ISSN | 1600-065X |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 302 |
Issue | 1 |
Pages | 228-240 |
DOI | https://doi.org/10.1111/imr.12977 |
Keywords | Immunology; Immunology and Allergy |
Public URL | https://nottingham-repository.worktribe.com/output/5574571 |
Publisher URL | https://onlinelibrary.wiley.com/doi/10.1111/imr.12977 |
Files
COVID-19 and pulmonary fibrosis
(761 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Complex roles of TGF-β signaling pathways in lung development and bronchopulmonary dysplasia
(2023)
Journal Article
Plasma cells: a feasible therapeutic target in pulmonary fibrosis?
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search